Photodynamic Therapy in Treating Patients With Skin Cancer
Completed
Roswell Park Cancer Institute
Phase 2
1993-11-01
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to
light to kill tumor cells. Photodynamic therapy using aminolevulinic acid cream may be
effective in treating patients with skin cancer.
PURPOSE: This randomized phase II trial is studying how well photodynamic therapy works in
treating patients with skin cancer.
Photodynamic Therapy in Treating Patients With Skin Cancer
Completed
National Cancer Institute (NCI)
Phase 2
1997-02-01
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to
light to kill tumor cells. Photodynamic therapy using aminolevulinic acid may be effective in
treating patients with skin cancer.
PURPOSE: This randomized phase II trial is studying how well photodynamic therapy that
includes aminolevulinic acid works in treating patients with skin cancer.
Photodynamic Therapy in Treating Patients With Skin Cancer
Completed
Roswell Park Cancer Institute
Phase 2
1997-02-01
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to
light to kill tumor cells. Photodynamic therapy using aminolevulinic acid may be effective in
treating patients with skin cancer.
PURPOSE: This randomized phase II trial is studying how well photodynamic therapy that
includes aminolevulinic acid works in treating patients with skin cancer.
Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia
Completed
National Cancer Institute (NCI)
Phase 2
1999-02-01
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to
light to kill cancer cells. Photosensitizing drugs such as aminolevulinic acid are absorbed
by cancer cells and, when exposed to light, become active and kill the cancer cells.
PURPOSE: Randomized phase II trial to study the effectiveness of photodynamic therapy using
aminolevulinic acid in treating patients who have cutaneous T-cell lymphoma, B-cell lymphoma,
or early chronic lymphocytic leukemia involving the skin.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
